Evidence map›Paper›PMID 25036884›Full record

ArticlePloS one2014

Cavin-3 knockout mice show that cavin-3 is not essential for caveolae formation, for maintenance of body composition, or for glucose tolerance.

Libin Liu, Carsten G Hansen, Brian J Honeyman, Benjamin J Nichols, Paul F Pilch

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Sca1Stem cell reviews and reports · 2021
    Article
  5. Review
  6. Article
  7. Lung Endothelial Transcytosis.Comprehensive Physiology · 2020
    Review
  8. Caveolae as Potential Hijackable Gates in Cell Communication.Frontiers in cell and developmental biology · 2020
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Libin LiuDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Carsten G HansenLaboratory of Molecular Biology, Medical Research Council, Cambridge, Cambridgeshire, United Kingdom.
Brian J HoneymanDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Benjamin J NicholsLaboratory of Molecular Biology, Medical Research Council, Cambridge, Cambridgeshire, United Kingdom.
Paul F PilchDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Boston University · USMedical Research Council · GB

Funding

High-throughput targeted mutagenesis of mouse stem cell linesU01HG004080 · NHGRI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DE JONG, PIETER J. · 2006 to 2010
$28.1M
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES CellsU01HG004085 · NHGRI · REGENERON PHARMACEUTICALS, INC. · PI VALENZUELA, DAVID MANUEL · 2006 to 2010
$25.3M
Boston University Clinical and Translational Science Award (CTSA) Program UL1UL1TR000157 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2012 to 2013
$7.9M
UCD KOMP PROJECT REPOSITORYU42RR024244 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2007 to 2010
$7.9M
Caveolae and adipocyte lipid metabolismR01DK097708 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PILCH, PAUL F · 2013 to 2017
$2.0M
Adiporedoxin, a Novel Player in Adipokine SecretionR01DK092942 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PILCH, PAUL F · 2012 to 2015
$1.4M
Medical Research Council MC_U105178778NCATS NIH HHS UL1 TR000157NCATS NIH HHS UL1-TR000157NCRR NIH HHS U42 RR024244NCRR NIH HHS U42RR024244NHGRI NIH HHS U01 HG004080NHGRI NIH HHS U01HG004080NHGRI NIH HHS U01 HG004085NHGRI NIH HHS U01HG004085NIDDK NIH HHS DK092942NIDDK NIH HHS DK097708NIDDK NIH HHS R01 DK092942NIDDK NIH HHS R01 DK097708
6 · The paper itself

Abstract

The cavins are a family of proteins associated with caveolae, cavin-1, -2 and -3 being widely expressed while cavin-4 is restricted to striated muscle. Deletion of cavin-1 results in phenotypes including metabolic changes consistent with adipocyte dysfunction, and caveolae are completely absent. Deletion of cavin-2 causes tissue-specific loss of caveolae. The consequences of cavin-3 deletion are less clear, as there are divergent data on the abundance of caveolae in cavin-3 null mice. Here we examine the consequences of cavin-3 deficiency in vivo by making cavin-3 knockout mice. We find that loss of cavin-3 has minimal or no effects on the levels of other caveolar proteins, does not appear to play a major role in formation of protein complexes important for caveolar morphogenesis, and has no significant effect on caveolae abundance. Cavin-3 null mice have the same body weight and fat mass as wild type animals at ages 8 through 30 weeks on both normal chow and high fat diets. Likewise, the two mouse strains exhibit identical glucose tolerance tests on both diets. Microarray analysis from adipose tissue shows that the changes in mRNA expression between cavin-3 null and wild type mouse are minimal. We conclude that cavin-3 is not absolutely required for making caveolae, and suggest that the mechanistic link between cavin-3 and metabolic regulation remains uncertain.

Indexed as

AdipocytesAdipose TissueAnimalsBody CompositionBody WeightCaveolaeDiet, High-FatFemaleGlucoseGlucose Tolerance TestMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMorphogenesisCavin1 protein, mouseGlucoseMembrane ProteinsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID25036884
PMCPMC4103889
OpenAlexW2114703897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.